Bookmark and Share

Last Minute:          For more news, click here.

Authentication
       
       
Remember me? 

Rise of
+0.56 (+0.90%) Bristol-Myers Squ - [Ticker: BMY]Chart Bristol-Myers Squ  News Bristol-Myers Squ  Download Historical Prices for Metastock Bristol-Myers Squ and Others  Technical Analysis Bristol-Myers Squ  
Last Trade62.22Last Trade Time2017-11-01 - 19:35:00
Variation+0.56 (+0.90%)Open61.86
High62.31Low61.49
Volume3,541,547Average Volume (3m)0
YieldBid / Ask62.21 x 900 - 62.22 x 1,400
Former Close61.6652 Week Range[0.00 - 0.00]
PER0.00%EPS0.00
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
Bristol-Myers Squ -  [Ticker: BMY] chart
Change to Bristol-Myers Squ Interactive Technical Analysis Chart

Last 10 Forum Topics about Bristol-Myers Squ:
No topics about Bristol-Myers Squ [BMY] have been found, but a search on the Forum for more topics related to Bristol-Myers Squ is advised.

 News about Bristol-Myers Squ [BMY]:   (ordered by relevance)
  1. Bristol Myers Squibb Reports Second Quarter Financial Results for 2022  Bristol-Myers Squibb
  2. Bristol Myers Squibb (BMY) Q2 2022 Earnings Call Transcript  The Motley Fool
  3. Bristol-Myers Squibb: Q2 Performance Confirms Bullish Stance (NYSE:BMY)  Seeking Alpha
  4. The Generics Are Here For This Pharma Mammoth  Investor's Business Daily
  5. Bristol Myers Stock Drops After 'Fairly Uninspiring' Earnings Beat  Barron's
  1. What?s Next For Bristol Myers Squibb Stock?  Forbes
  2. Earning 10% Income On Bristol Myers Squibb With Options (NYSE:BMY)  Seeking Alpha
  3. Bristol-Myers Squibb Company (BMY): Investing has never been easier  Invest Chronicle
  4. Bristol-Myers Squibb Company [BMY] Stock trading around $73.80 per share: What?s Next?  DBTNews
  5. Bristol-Myers Squibb Company (BMY): The long term indicators on the stock call for a Buy today ? The Baxter Report  The Baxter Report
Bristol Myers Squibb - Bristol Myers Squibb Announces Extension of Turning Point Tender Offer  Bristol-Myers Squibb What To Expect From Bristol Myers Squibb Stock After Q2 Results?  Forbes Bristol Myers Gets CHMP Backing for Opdualag in Advanced Melanoma >BMY  MarketWatch Bristol Myers Squibb Teams Up with Jack and Jill of America Inc. to Expand Tomorrow's Innovators Program to Increase Black Representation in the Healthcare Industry  PharmiWeb.com Bristol Myers discloses $39 mln in Russia exit costs  Reuters.com Bristol Myers Squibb to Host Virtual Investor Event to Discuss ESC 2022 Highlights  Business Wire Earnings Preview: Bristol Myers Squibb (BMY) Q2 Earnings Expected to Decline  Nasdaq Bristol-Myers Squibb (BMY) Reports CheckMate -914 Trial Evaluating Opdivo Plus Yervoy Did Not Meet Endpoint  StreetInsider.com Bristol Myers Squibb Co. stock outperforms competitors on strong trading day  MarketWatch Bristol Myers Squibb Co. stock rises Thursday, still underperforms market  MarketWatch Midyear stock changes show pharma's winners and losers  FiercePharma Bristol Myers Squibb - Bristol Myers Squibb Reports First Quarter Financial Results for 2022  Bristol-Myers Squibb 2 Top Healthcare Stocks to Buy Right Now  Nasdaq Bristol Myers Squibb - Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021  Bristol-Myers Squibb Drug, Biotech Stocks' Q2 Earnings on Jul 27: BMY, GSK & More  Nasdaq Bristol Myers Squibb - Bristol Myers Squibb to Highlight Long-Term Growth Strategy at J.P. Morgan's 40th Annual Healthcare Conference  Bristol-Myers Squibb 3 Unstoppable Stocks That Don't Care About the Bear Market  The Motley Fool Bristol Myers Squibb - LOTTE to Purchase Bristol Myers Squibb Manufacturing Facility in East Syracuse, New York  Bristol-Myers Squibb Is There More Room For Growth In Bristol Myers Squibb Stock?  Forbes Bristol Myers Squibb - Bristol Myers Squibb to Demonstrate the Strength of its Growing Cardiovascular Portfolio at the American College of Cardiology's 71st Annual Scientific Session  Bristol-Myers Squibb What?s Happening With Bristol Myers Squibb Stock?  Forbes Bristol Myers must face $6.4 bln lawsuit over delayed cancer drug  Reuters Bristol Myers Squibb (BMY): Safe Spot For Worrisome Investor  Seeking Alpha Bristol Myers Squibb - Bristol Myers Squibb Awards Nearly $8 Million in New Health Equity Grants to Improve Access to Care for Medically Underserved Patients in U.S.  Bristol-Myers Squibb Bristol-Myers Squibb Company's (BMY) CEO Giovanni Caforio Presents at Bernstein 38th Annual Strategic Decisions Conference (Transcript)  Seeking Alpha Bristol Myers Squibb Stock: Downgrade To Hold Now (NYSE:BMY)  Seeking Alpha Bristol Myers Squibb Stock Is Likely To Offer Better Returns Over This Life Sciences Company  Forbes Here?s Why Bristol Myers Squibb Stock Is A Better Pick Over This Pharmaceutical Bellwether  Forbes Bristol Myers Squibb (BMY) Q1 2022 Earnings Call Transcript  The Motley Fool New Two-Year Deucravacitinib Data Reinforce Durable Efficacy and Consistent Safety Profile in Treatment of Moderate to Severe Plaque Psoriasis  Bristol-Myers Squibb Prothena (PRTA) Q2 Earnings Miss, Pipeline Progress in Focus  Nasdaq 3 Unstoppable Dividend Stocks to Buy in August  Nasdaq Bristol Myers Squibb (NYSE:BMY): Still On Track  Seeking Alpha Bristol Myers Squibb (BMY) Stock Moves -0.55%: What You Should Know  Nasdaq Bristol Myers Squibb - Nektar and Bristol Myers Squibb Announce Update on Clinical Development Program for Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab)  Bristol-Myers Squibb 5 Charts That Show Why Bristol-Myers Squibb Is a No-Brainer Buy  The Motley Fool Bristol Myers Squibb: Fading The Rally Before Earnings (BMY)  Seeking Alpha Bristol Myers Squibb Announces Dividend  Business Wire Is A Rise Imminent For Bristol Myers Squibb Stock?  Forbes Bristol Myers Squibb to Participate in Bank of America Securities 2022 Healthcare Conference  Bristol-Myers Squibb Few U.S. patients with hepatitis C get timely treatment, CDC says  Reuters Bristol Myers Squibb: Bull Thesis Supported By Technicals (NYSE:BMY)  Seeking Alpha Noteworthy ETF Inflows: DGRO, BMY, AMGN, CMCSA  Nasdaq Bristol Myers Squibb: A Safe Haven In Times Of Uncertainty  Seeking Alpha BMY Stock: Bristol Expects $10.5 Billion Shortfall This Year As Generics Loom | Investor's Business Daily  Investor's Business Daily Bristol Myers Squibb - Bristol Myers Squibb Announces New Prescription Drug User Fee Act Goal Date for Reblozyl® (luspatercept-aamt) Supplemental Biologics License Application  Bristol-Myers Squibb What?s Next For Bristol Myers Squibb Stock After An 11% Fall In A Month?  Forbes Bristol Myers Squibb Stock: Looks Strong In 2022 (NYSE:BMY)  Seeking Alpha Is Bristol Myers Squibb Stock A Better Pick Over This Vaccine Company?  Forbes Bristol Myers Squibb - Bristol Myers Squibb Presents Interim Results from Long-Term Study Reinforcing Maintenance of Response and Safety Profile of Zeposia (ozanimod) in Patients with Moderately to Severely Active Ulcerative Colitis  Bristol-Myers Squibb Bristol Myers Squibb - Bristol Myers Squibb Receives European Commission Approval for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Certain Forms of Relapsed or Refractory Large B-cell Lymphoma  Bristol-Myers Squibb Is Bristol-Myers Squibb Company's (NYSE:BMY) 20% ROE Strong Compared To Its Industry?  Simply Wall St Bristol Myers Squibb to Report Results for Second Quarter 2022 on July 27, 2022  Business Wire Bristol-Myers Squibb Stock Is A Strong Buy On Future Growth Potential (NYSE:BMY)  Seeking Alpha Bristol Myers Squibb Announces Early Participation Results, Upsizing and Early Settlement of Tender Offers  Business Wire Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers  Business Wire 7 Best Pharmaceutical Stocks to Buy Now  Nasdaq Best Stocks for 2022: Bristol-Myers Squibb Is Having a Great Year  InvestorPlace Bristol-Myers Squibb Snags Another Approval for This Mega-Blockbuster Drug  The Motley Fool Ad hoc: Evotec and Bristol Myers Squibb extend and expand strategic partnership  Evotec What To Expect From Bristol Myers Squibb Stock After Q3 Results?  Forbes Bristol-Myers, Novartis win FDA label expansions for cancer medications (NYSE:BMY)  Seeking Alpha Bristol Myers Squibb My Choice For Dividend Growth (NYSE:BMY)  Seeking Alpha Clovis (CLVS) Q2 Loss Wider Than Expected, Revenues Miss  Nasdaq Bristol Myers Squibb Stock: Bull vs. Bear  The Motley Fool Bristol Myers Squibb to Participate in Bernstein's 38th Annual Strategic Decisions Conference  Business Wire Bristol Myers Squibb: It's The Best Time Ever To Buy BMY Stock  Seeking Alpha BMY Stock: How A $4.1 Billion Buyout Is Leveraging Its Cancer Regime  Investor's Business Daily Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know  Nasdaq What's Behind Bristol Myers Squibb's Latest Partnership?  The Motley Fool Medicare Drug Pricing Changes Could Be Coming: Time to Ditch Pharma Stocks?  Nasdaq Bristol-Myers Squibb downgraded at Morgan Stanley (NYSE:BMY)  Seeking Alpha Bristol Myers Squibb to Report Results for First Quarter 2022 on April 29, 2022  Business Wire Bristol Myers Squibb (BMY) Stock: $81 Price Target And Outperform Rating  Pulse 2.0 UPDATE: Bristol Myers triples-down on Immatics, bringing deal to $4.2B total biobucks. Why not just buy it?  FierceBiotech Here's A Better Pharmaceutical Pick Over Merck Stock  Forbes Here's Why Bristol Myers Squibb Stock Is A Better Pick Over This Pharmaceutical Bellwether  Nasdaq BBIO stock climbs after agreement with Bristol Myers Squibb (NYSE:BMY)  Seeking Alpha Bristol Myers posts long-term data for heart-disease drug in late-stage trial (NYSE:BMY)  Seeking Alpha Bristol Myers Squibb to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference  Business Wire Evotec achieves programme designation in neuroscience collaboration with Bristol Myers Squibb  Evotec Bristol Myers Squibb (BMY) Stock: $64 Price Target From Morgan Stanley  Pulse 2.0 Kirkland Represents Bristol-Myers Squibb Company on Offering of $6B of Senior Notes | News  Kirkland & Ellis LLP Bristol Myers Squibb Selects ZS To Support Global Commercialization and Analytics Capabilities  Business Wire Bristol Myers Squibb Prices $6 Billion of Senior Unsecured Notes  Business Wire Bristol Myers Squibb Stock: Value Time Again (NYSE:BMY)  Seeking Alpha Bristol Myers Squibb: Should You Buy the Dip?  The Motley Fool BeiGene's 2nd-quarter sales more than double  The Pharma Letter Here's Why Bristol Myers Squibb Stock Is Heating Up Today  The Motley Fool Teva Pharmaceutical Stock: Gem Among Generic Pharma Companies (NYSE:TEVA)  Seeking Alpha Bristol Myers Squibb to Present at J.P. Morgan's 40th Annual Healthcare Conference  Business Wire FDA approves expanded use of Bristol Myers cancer drug Opdivo  Reuters.com Bristol Myers must face a lawsuit filed by former Celgene shareholders  FiercePharma What Does This Regulatory News Mean for Bristol Myers Squibb's Shareholders?  The Motley Fool Neoadjuvant Opdivo (nivolumab) with Chemotherapy Significantly Improves Event-Free Survival in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial  Bristol-Myers Squibb Bristol Myers Launching Nine New Drugs After Bulking Up Pipeline  Bloomberg U.S. FDA approves new Bristol Myers cancer immunotherapy  Reuters.com U.S. Food and Drug Administration Approves First LAG-3-Blocking Antibody Combination, Opdualag? (nivolumab and relatlimab-rmbw), as Treatment for Patients with Unresectable or Metastatic Melanoma  Bristol-Myers Squibb
For more news about Bristol-Myers Squ click here:
Bristol-Myers Squ News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 - TR4DER.com, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources